The production of complex active pharmaceutical ingredients (APIs) continues to be one of the major technological challenges of the modern pharmaceutical industry. Many innovative medicines used in therapeutic areas such as oncology, infectious diseases, or viral pathologies are based on molecules of natural origin with highly complex chemical structures. However, obtaining these molecules directly from